Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,948 | 354 | 94.8% |
| Education | $378.97 | 4 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,055 | 128 | $0 (2024) |
| Amgen Inc. | $1,100 | 40 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $903.32 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $639.63 | 31 | $0 (2024) |
| Lilly USA, LLC | $595.44 | 34 | $0 (2024) |
| Janssen Biotech, Inc. | $418.56 | 26 | $0 (2024) |
| PFIZER INC. | $366.17 | 18 | $0 (2024) |
| UCB, Inc. | $271.84 | 15 | $0 (2024) |
| LEO Pharma Inc. | $262.20 | 10 | $0 (2024) |
| Incyte Corporation | $127.09 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,614 | 119 | E.R. Squibb & Sons, L.L.C. ($611.11) |
| 2023 | $1,818 | 90 | ABBVIE INC. ($340.36) |
| 2022 | $1,490 | 78 | ABBVIE INC. ($635.02) |
| 2021 | $1,405 | 71 | AbbVie Inc. ($708.04) |
All Payment Transactions
358 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Immunology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.21 | General |
| Category: Immunology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.58 | General |
| Category: Immunology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.47 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.48 | General |
| Category: Immunology | ||||||
| 12/11/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Inflammation & Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Immunology | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $107.25 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.70 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.79 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Immunology | ||||||
| 10/21/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $113.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.11 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,002 | 1,520 | $330,995 | $58,949 |
| 2022 | 7 | 502 | 703 | $134,313 | $29,577 |
| 2021 | 8 | 487 | 694 | $122,918 | $32,672 |
| 2020 | 4 | 409 | 536 | $76,188 | $19,515 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 383 | 457 | $118,398 | $20,829 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 231 | $84,847 | $15,334 | 18.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 141 | 169 | $32,582 | $5,731 | 17.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 78 | 78 | $25,267 | $4,422 | 17.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $17,311 | $2,850 | 16.5% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 23 | 23 | $11,948 | $2,278 | 19.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 22 | $10,954 | $2,075 | 18.9% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 17 | 19 | $11,279 | $2,060 | 18.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 95 | 452 | $8,596 | $1,707 | 19.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 19 | 20 | $5,604 | $939.93 | 16.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 12 | 13 | $4,210 | $722.55 | 17.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 189 | 214 | $44,886 | $10,111 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 137 | $40,359 | $9,067 | 22.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 74 | 74 | $20,037 | $4,039 | 20.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 64 | 69 | $11,264 | $2,560 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $11,864 | $2,419 | 20.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 34 | 167 | $2,676 | $706.35 | 26.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 13 | 13 | $3,228 | $674.26 | 20.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 103 | 144 | $38,448 | $11,706 | 30.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 139 | 161 | $29,624 | $8,432 | 28.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 52 | 52 | $21,112 | $4,734 | 22.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 65 | 65 | $17,225 | $3,874 | 22.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 60 | 67 | $10,720 | $2,478 | 23.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 13 | 14 | $3,416 | $854.20 | 25.0% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 39 | 150 | $2,250 | $551.73 | 24.5% |
About Gary Risko, PAC
Gary Risko, PAC is a Physician Assistant healthcare provider based in Johnstown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467559682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gary Risko, PAC has received a total of $7,327 in payments from pharmaceutical and medical device companies, with $2,614 received in 2024. These payments were reported across 358 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($6,948).
As a Medicare-enrolled provider, Risko has provided services to 2,400 Medicare beneficiaries, totaling 3,453 services with total Medicare billing of $140,714. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Johnstown, PA
- Active Since 09/20/2006
- Last Updated 12/19/2007
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1467559682
Products in Payments
- Sotyktu (Drug) $903.32
- RINVOQ (Biological) $819.98
- SKYRIZI (Biological) $807.65
- Otezla (Drug) $748.66
- TALTZ (Drug) $463.80
- TREMFYA (Drug) $361.71
- Enbrel (Biological) $351.47
- COSENTYX (Drug) $336.47
- HUMIRA (Biological) $257.49
- ADBRY (Biological) $237.24
- CIBINQO (Drug) $173.50
- LITFULO (Drug) $146.78
- Cimzia (Drug) $141.81
- OLUMIANT (Drug) $131.64
- Bimzelx (Biological) $130.03
- VTAMA (Drug) $107.46
- COSENTYX (Biological) $106.96
- ILUMYA (Biological) $69.07
- REMICADE (Biological) $56.85
- DUPIXENT (Biological) $51.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Johnstown
Travis Rudge, Pac, PAC
Physician Assistant — Payments: $12,102
Camille Miller, Pa-C, Mpas, PA-C, MPAS
Physician Assistant — Payments: $10,980
James Gides, Pa-C, PA-C
Physician Assistant — Payments: $9,444
Mrs. Taylor Flick, Pac, PAC
Physician Assistant — Payments: $8,116
Mr. Eric Krinsky, Pa-C, PA-C
Physician Assistant — Payments: $6,684
Ileana Blackburn, Pa-C, PA-C
Physician Assistant — Payments: $5,741